Cargando…

Safety of Renal Biopsy by Physicians with Short Nephrology Experience

Percutaneous renal biopsy is an essential tool for diagnosing various renal diseases; however, little is known about whether renal biopsy performed by physicians with short nephrology experience is safe in Japan. This study included 238 patients who underwent percutaneous renal biopsy between April...

Descripción completa

Detalles Bibliográficos
Autores principales: Torigoe, Kenta, Muta, Kumiko, Tsuji, Kiyokazu, Yamashita, Ayuko, Abe, Shinichi, Ota, Yuki, Mukae, Hiroshi, Nishino, Tomoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072574/
https://www.ncbi.nlm.nih.gov/pubmed/33923650
http://dx.doi.org/10.3390/healthcare9040474
_version_ 1783683938271625216
author Torigoe, Kenta
Muta, Kumiko
Tsuji, Kiyokazu
Yamashita, Ayuko
Abe, Shinichi
Ota, Yuki
Mukae, Hiroshi
Nishino, Tomoya
author_facet Torigoe, Kenta
Muta, Kumiko
Tsuji, Kiyokazu
Yamashita, Ayuko
Abe, Shinichi
Ota, Yuki
Mukae, Hiroshi
Nishino, Tomoya
author_sort Torigoe, Kenta
collection PubMed
description Percutaneous renal biopsy is an essential tool for diagnosing various renal diseases; however, little is known about whether renal biopsy performed by physicians with short nephrology experience is safe in Japan. This study included 238 patients who underwent percutaneous renal biopsy between April 2017 and September 2020. We retrospectively analyzed the frequency of post-renal biopsy complications (hemoglobin decrease of ≥10%, hypotension, blood transfusion, renal artery embolization, nephrectomy and death) and compared their incidence among physicians with varied experience in nephrology. After renal biopsy, a hemoglobin decrease of ≥10%, hypotension and transfusion occurred in 13.1%, 3.8% and 0.8% of patients, respectively. There were no cases of post-biopsy renal artery embolism, nephrectomy, or death. The composite complication rate was 16.0%. The incidence of post-biopsy complications was similar between physicians with ≥3 years and <3 years of clinical nephrology experience (12.5% vs. 16.8%, p = 0.64). Furthermore, the post-biopsy composite complication rates were similar between physicians with ≥6 months and <6 months of clinical nephrology experience (16.3% vs. 15.6%, p > 0.99). Under attending nephrologist supervision, a physician with short clinical nephrology experience can safely perform renal biopsy.
format Online
Article
Text
id pubmed-8072574
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80725742021-04-27 Safety of Renal Biopsy by Physicians with Short Nephrology Experience Torigoe, Kenta Muta, Kumiko Tsuji, Kiyokazu Yamashita, Ayuko Abe, Shinichi Ota, Yuki Mukae, Hiroshi Nishino, Tomoya Healthcare (Basel) Article Percutaneous renal biopsy is an essential tool for diagnosing various renal diseases; however, little is known about whether renal biopsy performed by physicians with short nephrology experience is safe in Japan. This study included 238 patients who underwent percutaneous renal biopsy between April 2017 and September 2020. We retrospectively analyzed the frequency of post-renal biopsy complications (hemoglobin decrease of ≥10%, hypotension, blood transfusion, renal artery embolization, nephrectomy and death) and compared their incidence among physicians with varied experience in nephrology. After renal biopsy, a hemoglobin decrease of ≥10%, hypotension and transfusion occurred in 13.1%, 3.8% and 0.8% of patients, respectively. There were no cases of post-biopsy renal artery embolism, nephrectomy, or death. The composite complication rate was 16.0%. The incidence of post-biopsy complications was similar between physicians with ≥3 years and <3 years of clinical nephrology experience (12.5% vs. 16.8%, p = 0.64). Furthermore, the post-biopsy composite complication rates were similar between physicians with ≥6 months and <6 months of clinical nephrology experience (16.3% vs. 15.6%, p > 0.99). Under attending nephrologist supervision, a physician with short clinical nephrology experience can safely perform renal biopsy. MDPI 2021-04-16 /pmc/articles/PMC8072574/ /pubmed/33923650 http://dx.doi.org/10.3390/healthcare9040474 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Torigoe, Kenta
Muta, Kumiko
Tsuji, Kiyokazu
Yamashita, Ayuko
Abe, Shinichi
Ota, Yuki
Mukae, Hiroshi
Nishino, Tomoya
Safety of Renal Biopsy by Physicians with Short Nephrology Experience
title Safety of Renal Biopsy by Physicians with Short Nephrology Experience
title_full Safety of Renal Biopsy by Physicians with Short Nephrology Experience
title_fullStr Safety of Renal Biopsy by Physicians with Short Nephrology Experience
title_full_unstemmed Safety of Renal Biopsy by Physicians with Short Nephrology Experience
title_short Safety of Renal Biopsy by Physicians with Short Nephrology Experience
title_sort safety of renal biopsy by physicians with short nephrology experience
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072574/
https://www.ncbi.nlm.nih.gov/pubmed/33923650
http://dx.doi.org/10.3390/healthcare9040474
work_keys_str_mv AT torigoekenta safetyofrenalbiopsybyphysicianswithshortnephrologyexperience
AT mutakumiko safetyofrenalbiopsybyphysicianswithshortnephrologyexperience
AT tsujikiyokazu safetyofrenalbiopsybyphysicianswithshortnephrologyexperience
AT yamashitaayuko safetyofrenalbiopsybyphysicianswithshortnephrologyexperience
AT abeshinichi safetyofrenalbiopsybyphysicianswithshortnephrologyexperience
AT otayuki safetyofrenalbiopsybyphysicianswithshortnephrologyexperience
AT mukaehiroshi safetyofrenalbiopsybyphysicianswithshortnephrologyexperience
AT nishinotomoya safetyofrenalbiopsybyphysicianswithshortnephrologyexperience